Piper Sandler cuts Nutanix stock price target on supply concerns

The market is still underpricing the durability of Nutanix’s mix shift toward higher-quality recurring revenue, but the immediate upside is increasingly about operating leverage rather than top-line acceleration. If duration-extension is doing meaningful work this quarter, that is a temporary tailwind: it lifts near-term bookings/ARR optics but can mask weaker underlying consumption behavior and pull forward revenue that would otherwise support next year. That makes the stock vulnerable to a sharper reset if renewal cohorts normalize faster than management can offset with migration wins.

The second-order winner is not just NTNX itself but the VMware displacement ecosystem: systems integrators, migration services, and adjacent infrastructure vendors should continue to see project flow as customers de-risk legacy estates. However, the same dynamic eventually commoditizes the migration story, because the easiest wins are front-loaded and the addressable base becomes progressively smaller and more price-sensitive. In other words, the near-term narrative is “share gains,” but the medium-term debate shifts to whether NTNX can sustain bookings growth once the initial migration wave matures.

The main risk is not a catastrophic demand break; it is a 2-3 quarter deceleration in renewal quality that forces multiple compression before the next upside catalyst arrives. At roughly mid-teens FCF multiple on current expectations, the market is paying for execution continuity, so any hint that fiscal 2027 renewals are softer will hit the stock disproportionately. Conversely, if next quarter confirms that OEM and NC2 are becoming repeatable attach points rather than one-off drivers, the name can re-rate back toward the higher end of analyst targets even without an earnings beat.

Consensus appears to be leaning too hard on the idea that improved margins and FCF automatically justify upside from here. The more important question is whether current strength is being pulled forward from future periods; if so, the visible guidance improvement may be less durable than the headline suggests. That makes this a good stock to own tactically into confirmation, but not one to chase aggressively after a multi-analyst upgrade cluster.